热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　昭衍新药（06127）早盘上涨5%，现报8.82港元，成交额963.97万港元。

　　消息面上，昭衍新药发盈警，预计2024年实现营业收入约人民币19.17亿元到21.19亿元，同比下降约10.8%到19.3%；预计2024年实现归属于公司股东的净利润约人民币5868.80万元到8803.20万元，同比下降约77.8%到85.2%。值得注意的是，昭衍新药2024年前三季度归属于上市公司股东的净亏损7030.71万元，以此计算，该公司去年第四季度的净利润预计约1.2亿-1.5亿。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.